Condition
Persistent Pulmonary Hypertension
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 1 (1)
P 2 (1)
Trial Status
Completed3
Withdrawn1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07090720Not ApplicableCompleted
Melatonin Effects on the Left Ventricular Function in Neonates With Persistent Pulmonary Hypertension
NCT04391478Phase 1CompletedPrimary
Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension
NCT01409031Phase 2TerminatedPrimary
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
NCT01310153Not ApplicableCompleted
Effect of Supine or Prone Position After Caesarean Birth
NCT00216931Not ApplicableWithdrawnPrimary
Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost
Showing all 5 trials